ContractopenCA
FG-2101: A FIRST-IN-CLASS LPXC INHIBITOR FOR THE TREATMENT OF MDR GRAMNEGATIVE URINARY TRACT INFECTIONS.
National Institutes of HealthDescription
FG-2101: A FIRST-IN-CLASS LPXC INHIBITOR FOR THE TREATMENT OF MDR GRAMNEGATIVE URINARY TRACT INFECTIONS. Recipient: BLACKSMITH MEDICINES, INC. Award Amount: $10.98M
Requirements
Source: USASpending.gov
Interested in this contract?
Sign up to get match scores, track opportunities, and manage proposals with AI-powered tools.
Contract Details
Value Range
Up to $10,980,000
Deadline
December 31, 2026
Geographic Scope
CA
Status
open
External Links
View Original ListingSee how well this contract matches your organization.
Get Your Match Score